SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
BTK 5,254-0.1%Apr 29 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (49655)2/21/2018 1:42:13 PM
From: software salesperson   of 51531
 
Beta-Amyloid is Most Common Target

Despite a history of failures, 30 drugs in clinical trials are targeting beta-amyloid, a misfolded

protein that comprises the plaques found in

Alzheimer’s. An additional 11 drugs target other

misfolded proteins such as tau or mechanisms to

clear such proteins.







alzdiscovery.org

you can search on "tau" to find each one.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext